Physician profile
Allison Henderson
NPI 1831142298
$353.90
in general payments reported to CMS, 2019-2025
14 companies · $13.85 in 2025
The $13.85 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109 · 2020: $17.65 · 2021: $48.06 · 2022: $52.84 · 2023: $57.24 · 2024: $55.26 · 2025: $13.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $126.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $74.63 | 2022-2024 | Azstarys |
| Cranial Technologies, INC | $49.78 | 2019-2021 | |
| Supernus Pharmaceuticals, INC. | $32.86 | 2022-2024 | Qelbree |
| Glaxosmithkline, LLC. | $29.57 | 2019 | |
| Tris Pharma INC | $21.00 | 2023 | Dyanavel Xr |
| Ultragenyx Pharmaceutical INC. | $19.87 | 2021 | |
| Abbott Laboratories | $18.71 | 2024 | Id Now Instrument |
| Neos Therapeutics, LP | $18.14 | 2022 | |
| Genentech USA, INC. | $17.65 | 2020 | |
| Lupin INC. | $16.56 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.16 | 2019 | |
| Sanofi Pasteur INC. | $15.09 | 2021 | |
| Alk-Abello, INC | $13.85 | 2025 | Neffy |
| Mission Pharmacal Company | $11.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Henderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.